Enalapril is safe during breastfeeding
Enalapril is specifically recommended as a safe option for breastfeeding mothers with hypertension 1, 2. Multiple high-quality guidelines from 2020 explicitly list enalapril (along with captopril) as acceptable oral drugs for lactation 1.
Evidence Supporting Safety
The most recent and authoritative guidelines consistently support enalapril use during lactation:
Hypertension Canada 2020 Guidelines explicitly list enalapril as a Grade D recommended oral drug for lactation in their comprehensive hypertension management table 1
European Society of Cardiology/European Society of Hypertension 2020 Position Paper specifically states that "labetalol, nifedipine, enalapril, and metoprolol are considered safe for breastfeeding mothers" 2
2025 Circulation Guidelines list enalapril as a first-line agent for postpartum hypertension regardless of breastfeeding status, with once-daily dosing advantage 3
Pharmacologic Rationale
Enalapril has minimal transfer into breast milk, making it particularly suitable for lactation 2, 4. The drug demonstrates:
- Low milk-to-plasma (M/P) ratios 5
- Relative infant dose (RID) of only 1.1% - well below the 10% safety threshold 3
- Favorable pharmacokinetics for breastfeeding safety 2
A 2025 systematic review on drug safety in breastfeeding women with CKD confirmed that "among renin-angiotensin system inhibitors, enalapril and captopril are safe for breastfeeding" 4.
Important Caveats and Monitoring
While enalapril is safe, be aware of these considerations:
Theoretical concerns exist for premature infants: There is a theoretical risk of hypotension, particularly in premature infants or those with renal failure 1, 2. In these specific populations, closer monitoring may be warranted.
Contrast with pregnancy: While ACE inhibitors like enalapril are strictly contraindicated during pregnancy due to fetal renal toxicity 1, 6, this concern does not apply to breastfeeding. The FDA label notes that enalapril is detected in breast milk but does not contraindicate breastfeeding 7.
Postpartum timing: The 2003 JNC-7 guidelines suggested avoiding ACE inhibitors during lactation based on "adverse fetal and neonatal renal effects" 6, but this older recommendation has been superseded by more recent evidence showing safety when used postpartum in breastfeeding mothers.
Practical Prescribing
Start enalapril at 5 mg daily, with maximum dose of 40 mg daily (or 20 mg twice daily) 3. The once-daily dosing is a significant advantage over alternatives like labetalol, which requires twice-daily or more frequent administration 3.
Alternative first-line agents for breastfeeding include nifedipine, amlodipine, and labetalol, though recent data suggest labetalol may be less effective postpartum and associated with higher readmission risk 3.